| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $71,982 | 2 | 17 |
Sells | $2,041,953 | 10 | 83 |
| Zaderej Karen L. | director | 1 | $52,258 | 0 | $0 | $52,258 |
| Duker Jay S. | President and CEO | 1 | $19,724 | 0 | $0 | $19,724 |
| Lurker Nancy | director | 0 | $0 | 3 | $150,942 | $-150,942 |
| Cormorant Asset Management, LP | Former 10% Owner | 0 | $0 | 1 | $942,240 | $-942,240 |
| Ribeiro Ramiro | Chief Medical Officer | 0 | $0 | 6 | $948,771 | $-948,771 |
EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom. Among its commercialized product portfolio are ILUVIEN, an injectable, sustained-release micro-insert designed to treat diabetic macular edema, and YUTIQ, an intravitreal implant containing fluocinolone acetonide, which targets chronic non-infectious uveitis impacting the posterior segment of the eye. The company also offers DEXYCU, …
Over the last 12 months, insiders at EyePoint Pharmaceuticals, Inc. have bought $71,982 and sold $2.04M worth of EyePoint Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at EyePoint Pharmaceuticals, Inc. have bought $22.47M and sold $32.8M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Zaderej Karen L. (director) — $52,258. Duker Jay S. (President and CEO) — $19,724.
The last purchase of 10,600 shares for transaction amount of $52,258 was made by Zaderej Karen L. (director) on 2026‑08‑18.
| 2026-08-18 | Zaderej Karen L. | director | 10,600 0.0114% | $4.93 | $52,258 | -36.84% | ||
| 2026-06-30 | Sale | Ribeiro Ramiro | Chief Medical Officer | 4,875 0.0061% | $15.01 | $73,167 | -68.01% | |
| 2026-04-17 | Sale | Ribeiro Ramiro | Chief Medical Officer | 2,437 0.0029% | $15.00 | $36,555 | -17.65% | |
| 2026-03-16 | Duker Jay S. | President and CEO | 1,500 0.0018% | $13.15 | $19,724 | -6.39% | ||
| 2026-03-04 | Sale | Ribeiro Ramiro | Chief Medical Officer | 2,438 0.0029% | $17.87 | $43,572 | -28.72% | |
| 2026-02-17 | Sale | Ribeiro Ramiro | Chief Medical Officer | 2,437 0.003% | $15.00 | $36,555 | -13.41% | |
| 2026-01-05 | Sale | Ribeiro Ramiro | Chief Medical Officer | 42,544 0.0503% | $17.10 | $727,319 | -25.01% | |
| 2025-12-04 | Sale | Cormorant Asset Management, LP | Former 10% Owner | 60,000 0.0821% | $15.70 | $942,240 | -20.51% | |
| 2025-12-04 | Sale | Lurker Nancy | director | 9,300 0.0122% | $15.11 | $140,477 | -20.51% | |
| 2025-11-28 | Sale | Lurker Nancy | director | 500 0.0007% | $14.95 | $7,475 | -10.32% | |
| 2025-11-26 | Sale | Lurker Nancy | director | 200 0.0003% | $14.95 | $2,990 | -9.94% | |
| 2025-11-11 | Sale | Ribeiro Ramiro | Chief Medical Officer | 2,722 0.0041% | $11.61 | $31,602 | +14.59% | |
| 2025-05-19 | Zaderej Karen L. | director | 5,000 0.0071% | $5.99 | $29,950 | +117.21% | ||
| 2025-05-16 | Zaderej Karen L. | director | 5,000 0.0069% | $5.81 | $29,050 | +116.48% | ||
| 2025-05-15 | Zaderej Karen L. | director | 5,000 0.0069% | $5.47 | $27,350 | +131.64% | ||
| 2025-05-14 | Zaderej Karen L. | director | 5,000 0.0072% | $5.42 | $27,100 | +141.35% | ||
| 2024-08-21 | ANDO GORAN | director | 5,000 0.0082% | $7.95 | $39,750 | -8.84% | ||
| 2024-08-20 | DICICCO WENDY F | director | 2,567 0.0048% | $7.79 | $19,997 | +6.87% | ||
| 2024-08-19 | Zaderej Karen L. | director | 12,500 0.0235% | $7.98 | $99,750 | +3.84% | ||
| 2024-08-16 | Lurker Nancy | director | 3,173 0.0057% | $7.88 | $25,003 | +3.91% |
| Cormorant Asset Management, LP | Former 10% Owner | 8265000 9.8579% | $3.31M | 6 | 1 | <0.0001% |
| Lurker Nancy | director | 206547 0.2464% | $82,598.15 | 4 | 7 | <0.0001% |
| Duker Jay S. | President and CEO | 100665 0.1201% | $40,255.93 | 2 | 0 | <0.0001% |
| Zaderej Karen L. | director | 49100 0.0586% | $19,635.09 | 6 | 0 | +102.1% |
| EW Healthcare Partners, L.P. | 10 percent owner | 3490921 4.1637% | $1.4M | 2 | 9 | +60.73% |
| Elston George | Chief Financial Officer | 40000 0.0477% | $15,996.00 | 4 | 0 | +18.73% |
| Landis John B. | director | 40000 0.0477% | $15,996.00 | 1 | 0 | <0.0001% |
| Godshall Douglas Evan | director | 29500 0.0352% | $11,797.05 | 1 | 0 | <0.0001% |
| ANDO GORAN | director | 13150 0.0157% | $5,258.69 | 1 | 0 | <0.0001% |
| DICICCO WENDY F | director | 9967 0.0119% | $3,985.80 | 1 | 0 | +6.87% |
| Hopper Paul | director | 10000 0.0119% | $3,999.00 | 1 | 0 | +38.89% |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 4343 0.0052% | $1,736.77 | 1 | 1 | <0.0001% |
$2,542,362 | 111 | 11.81% | $36.83M | |
$156,891,025 | 80 | -24.91% | $36.3M | |
$84,911,583 | 59 | 17.82% | $37.44M | |
$693,326 | 47 | -16.24% | $40.24M | |
$6,204,522 | 45 | 1.91% | $36.5M |
| Increased Positions | 102 | +76.69% | 22M | +31.13% |
| Decreased Positions | 53 | -39.85% | 8M | -10.94% |
| New Positions | 33 | New | 8M | New |
| Sold Out Positions | 16 | Sold Out | 3M | Sold Out |
| Total Postitions | 182 | +36.84% | 84M | +20.19% |
| Cormorant Asset Management, Lp | $145,521.00 | 10.03% | 8.32M | 0 | 0% | 2025-09-30 |
| Suvretta Capital Management, Llc | $108,249.00 | 7.46% | 6.19M | -611,376 | -8.98% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $97,185.00 | 6.7% | 5.56M | -1M | -18.24% | 2025-09-30 |
| Blackrock, Inc. | $86,780.00 | 5.98% | 4.96M | -395,688 | -7.38% | 2025-09-30 |
| Federated Hermes, Inc. | $77,197.00 | 5.32% | 4.42M | -183,118 | -3.98% | 2025-09-30 |
| Franklin Resources Inc | $72,925.00 | 5.03% | 4.17M | -129,239 | -3% | 2025-09-30 |
| Vanguard Group Inc | $66,328.00 | 4.57% | 3.79M | -8,130 | -0.21% | 2025-09-30 |
| Tcg Crossover Management, Llc | $62,444.00 | 4.3% | 3.57M | 0 | 0% | 2025-09-30 |
| Citadel Advisors Llc | $37,327.00 | 2.57% | 2.14M | -208,821 | -8.91% | 2025-09-30 |
| Paradigm Biocapital Advisors Lp | $35,054.00 | 2.42% | 2.01M | +2M | New | 2025-09-30 |